Our Services
Medical Information
Helpful Resources
Published on: 3/12/2026
If you are still depressed after at least two adequate antidepressant trials, a psychiatrist who specializes in treatment-resistant depression can guide proven next steps like optimized medication strategies and augmentation, esketamine, TMS, ECT, ketamine infusions, and targeted psychotherapies.
There are several factors to consider. See below to understand how to confirm TRD, rule out look-alike conditions, find and vet the right specialist, prepare your treatment history, and know when to seek urgent help.
If you've tried one or more antidepressants and you're still struggling, you are not alone. Up to one-third of people with major depressive disorder do not respond fully to standard treatment. When depression doesn't improve after trying at least two different antidepressants at adequate doses and duration, doctors often call it treatment-resistant depression (TRD).
If this sounds familiar, it may be time to focus on finding a psychiatrist who specializes in TRD. These specialists are trained in advanced, evidence-based treatments that go beyond first-line medications.
Below, you'll learn what TRD really means, what next steps are medically proven, and how to find the right psychiatrist for your situation.
Treatment-resistant depression is not a personal failure. It is a medical condition.
Typically, TRD is diagnosed when:
TRD does not mean depression is untreatable. It simply means a more specialized approach is needed.
Not all psychiatrists focus on complex or resistant depression. A specialist in TRD is more likely to:
TRD often requires a personalized plan. A specialist understands how to adjust treatment safely and effectively.
If standard antidepressants haven't worked, there are next steps supported by strong research.
A TRD specialist may:
Common augmentation strategies may include:
These strategies are backed by clinical research and are commonly used in TRD.
Esketamine is approved specifically for treatment-resistant depression. It is given under medical supervision in a certified clinic.
It works differently from traditional antidepressants by targeting glutamate pathways in the brain.
Research shows:
Because it can affect blood pressure and perception temporarily, it must be administered in a controlled setting.
A psychiatrist who specializes in TRD will know whether you're a candidate.
TMS is a non-invasive brain stimulation therapy.
It involves:
TMS is FDA-cleared for major depression and has strong evidence supporting its use in TRD.
It's particularly appealing if:
ECT remains one of the most effective treatments for severe depression, including:
ECT is done under anesthesia in a hospital setting. Despite outdated stigma, modern ECT is safe and highly regulated.
For some patients, it is life-saving.
IV ketamine has growing evidence for rapid symptom relief in TRD. While esketamine is FDA-approved, IV ketamine is often used off-label.
Research supports:
A TRD specialist can discuss risks, benefits, and whether it's appropriate.
If you've tried therapy before, it doesn't mean therapy won't work.
Evidence-based therapies for TRD include:
A specialist may recommend combining psychotherapy with interventional treatment for better results.
Here are practical steps to take:
When searching online, use phrases like:
Academic medical centers often have TRD programs.
When calling a practice, ask:
A strong TRD psychiatrist should be comfortable answering these.
Look for:
Before your appointment, write down:
If you're unsure how to accurately describe what you're experiencing or want to better understand your symptoms before meeting with a specialist, take Ubie's free AI-powered depression symptom checker. It only takes a few minutes and can help you communicate more clearly with your doctor.
Sometimes depression doesn't improve because something else is going on.
A TRD specialist will evaluate for:
Proper diagnosis changes treatment.
It's normal to feel:
But here's the truth: many people labeled "treatment-resistant" do improve with the right strategy.
Progress may not be instant. It may take careful adjustment. But there are more options today than ever before.
If you are experiencing:
You should seek immediate medical care.
Treatment-resistant depression can be serious, and in some cases life-threatening. Speak to a doctor right away or go to the nearest emergency room if you are in immediate danger.
If you're still depressed after multiple treatments, that does not mean you are beyond help. It likely means you need a different level of care.
Finding a psychiatrist who specializes in TRD can open doors to:
Depression is a medical illness. When first-line treatments don't work, the next step isn't giving up — it's leveling up your care.
Consider starting by organizing your treatment history, completing a symptom check for Depression, and scheduling a consultation with a TRD specialist.
And most importantly: speak to a doctor about any symptoms that feel severe, worsening, or life-threatening. Help exists — even when it hasn't worked yet.
(References)
* McIntyre RS, Lophaven S, Olsen CK. The definition, classification, and treatment of treatment-resistant depression: a white paper. Ann Clin Psychiatry. 2020 Nov;32(4):e22-e35. PMID: 33132338.
* Sanacora G, Blier P, Blumberger DM, Bryant C, Dhas J, Hampson M, Husain MM, Mathew SJ, McAllister-Williams RH, McDonald WM, Moomba D, Potash JB, Roccaforte H, Segal S, Shelton RC, Sunderajan P, Thase ME. Treatment-Resistant Depression: A Guide for the Clinician. CNS Drugs. 2022 Jul;36(7):677-691. doi: 10.1007/s40263-022-00929-2. Epub 2022 Jul 7. PMID: 35802102.
* Fazzari JA, Daskalakis ZJ, Blumberger DM. Current and Emerging Neurostimulation Treatments for Major Depressive Disorder. Curr Treat Options Psychiatry. 2021;8(2):164-180. doi: 10.1007/s40501-021-00236-4. Epub 2021 May 17. PMID: 33996253.
* Ionescu DF, Averill LA, Krystal JH. Intranasal Esketamine for the Treatment of Treatment-Resistant Depression: A Systematic Review. CNS Drugs. 2021 Jul;35(7):743-756. doi: 10.1007/s40263-021-00827-0. PMID: 34002369.
* Baghai TC, Häring N, Böhme M, Schüle C, Bender A. Systematic Review and Network Meta-Analysis of Augmentation Strategies for Treatment-Resistant Depression. J Clin Psychopharmacol. 2022 Sep-Oct;42(5):456-465. doi: 10.1097/JCP.0000000000001582. Epub 2022 Aug 3. PMID: 35920364.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.